Meningioma gene changes differ across groups of people
Original title: Prospective consecutive genomic profiling defines the distribution of meningioma molecular alterations across demographic groups.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This looked at test results from people, but no treatment was tested.
The short version
Tumor gene changes linked to risk were not the same in every group of patients.
What was studied. Doctors ran gene tests on 1,104 tumor samples from 1,044 people with meningioma. All were treated or tested at one large US medical center from 2019 to 2025.
What they found. Tumors from Asian men more often had gene changes tied to higher risk. Tumors from women more often had gene changes tied to lower risk. Low grade tumors were more common in Hispanic people. Tumors from Hispanic and White patients otherwise looked alike.
What this means, and what it doesn't
What it could mean: Gene testing of a meningioma can help a doctor judge how risky it may be. This study says those test results can differ by group. Your care team may use them when planning checkups and treatment.
What it doesn't mean: This does not mean every Asian man will have an aggressive tumor. It does not mean women or Hispanic people are safe from one. The study only looked back at test results from care already given. No new treatment was tested. It is not a cure, and it does not change your care by itself.
Source: PubMed, August 19, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.